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Abstract
Background: Treatment delay is an important indicator of access to tuberculosis diagnosis and
treatment. Analyses of patient delay (i.e. time interval between onset of symptoms and first
consultation of a health care provider) and health care delay (i.e. time interval between first
consultation and start of treatment) can inform policies to improve access. This study assesses the
patient, health care provider and total delay in diagnosis and treatment of new smear-positive
pulmonary tuberculosis patients, and the risk factors for long delay, in Vietnam.
Methods: A cross-sectional survey of new patients treated by the National Tuberculosis Control
Programme was conducted in 70 randomly selected districts in Vietnam. All consecutively
registered patients in one quarter of 2002 were interviewed using a pre-coded structured
questionnaire.
Results: Median (range) delay was 4 weeks (1–48) for total, 3 (1–48) weeks for patient and 1 (0–
25) week for health care delay. Patients with long total delay (≥ 12 weeks, 15%) accounted for 49%
of the cumulative number of delay-weeks. Independent risk factors (p < 0.05) for long total delay
were female sex, middle age, remote setting, residence in the northern or central area, and initial
visit to the private sector. For long patient delay (≥ 6 weeks) this was female sex, belonging to an
ethnic minority, and living at > 5 km distance from a health facility or in the northern area. For long
health care delay (≥ 6 weeks) this was urban setting, residence in the central area and initial visit
to a communal health post, TB hospital or the private sector.
Conclusion: Analyses of patient and treatment delays can indicate target groups and areas for
health education and strengthening of the referral system, in particular between the private sector
and the NTP.
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Background
Delays in diagnosis and treatment of tuberculosis (TB) are
common. They may reflect patient delays in seeking care,
health care provider delays in making the diagnosis and
starting treatment, or both [1-7].
Diagnostic delay may result in more advanced and severe
disease, higher mortality and sustained spread of M. tuber-
culosis in the community as untreated persons continue to
transmit the infection to others [8,9]. Information on
diagnostic delay and its trend over time is thus important
for evaluation and improvement of TB control pro-
grammes.
Distributions of diagnostic delays tend to be skewed: they
are relatively short for most TB patients, but very long for
some [3,4]. Patients with long diagnostic delays may
therefore contribute disproportionately to the cumulative
delay of all patients and thereby, potentially, to TB trans-
mission. Prevention of these long delays could therefore
be more effective in curbing TB transmission than further
reduction of the median delay among all patients. There-
fore, it is also important to know the risk profile of
patients with long diagnostic delays.
Vietnam is among the 22 countries with a high TB burden.
In 2002, the National Tuberculosis Control Program
(NTP) detected 95,044 TB cases (118 per 100,000 popula-
tion), including 56,811 (71/100,000) new smear-positive
cases [10,11]. From 1997 onwards, the estimated case
detection rate of the NTP has been above the WHO target
of 70%. One would thus expect diagnostic delays to be
relatively short, but no nationally representative data are
available. A study in 4 provinces in Vietnam in 1996
showed a mean total delay among TB patients of 12 weeks
[12]; only small-scale studies of delay have been pub-
lished since [13-15]. In these studies, women had longer
delays than men, and more often had visited less qualified
health care providers before a diagnosis of TB was made
[12-15]. In the NTP, the district is the key level for diagno-
sis and treatment. Patients with TB symptoms can choose
any (private or public) health care provider or go directly
to the district TB unit (DTU). Referral to the DTU by pri-
vate health care providers tends to be limited [16]. The
growth of the private health sector may thus affect diag-
nostic delays [17,18].
We performed a nation-wide study of diagnostic delays in
70 randomly selected district TB units, with the aims of
assessing the extent of delay in case-finding and treatment
among TB patients diagnosed within the NTP, and identi-
fying risk factors associated with long delay, in particular
related to choice of initial health care provider.
Study population and methods
Eligible were all patients who were registered with newly
diagnosed smear-positive pulmonary TB in the third quar-
ter of 2002 in 70 district TB units. These districts had been
sampled for a national TB prevalence survey. Sampling
was with probability proportional to population size after
stratification by area, so that 20 urban, 20 remote and 30
rural districts were selected. Excluded were patients with
permanent or temporary residence outside the district.
Patient delay was defined as the period between the onset
of cough and the patient's first attendance of a health care
facility because of this cough. Health care provider (HCP)
delay was defined as the period between the patient's first
attendance of a health care facility with cough, and the
onset of treatment. Treatment delay was defined as the
period between diagnosis of smear-positive pulmonary
TB and the onset of treatment. Total delay was combined
patient and HCP delay. Delay periods were recorded in
weeks, rounded to the nearest integer value. Long patient
delays and health care provider delays were defined as 6
weeks or more and long total delay as 12 weeks or more.
Patients were interviewed using a pre-coded structured
questionnaire including demographic variables (age, sex,
ethnicity, education and distance from the patient's house
to the first health care provider); time period between
onset of cough and first contact with health care provider;
time period between onset of cough and start of treat-
ment; date of diagnosis; starting date of treatment. The
district TB coordinators were trained to perform inter-
views and interviewed patients within 2 weeks of treat-
ment registration. The study protocol was approved by the
Scientific and Ethical Board of the National Hospital
(then: Institute) of Tuberculosis and Respiratory Diseases,
Hanoi.
Data were double entered using Epi Info v6; inconsisten-
cies were checked against the raw data. Data were analysed
using Stata v8. The chi-square tests were used to compare
differences in proportions in total delay between sub-
groups. Because delays had non-normal distributions,
Wilcoxon Rank Sum and Kruskal-Wallis tests were use to
test for significance. Mean delays are nonetheless reported
for comparison with other studies. Uni- and multivariate
logistic regression analysis was used to identify risk factors
that were associated with long delay. We tested for signif-
icance using the likelihood ratio test for comparing the
model likelihood with and without the variable or inter-
action term of interest.
Results
During the study period, 2,093 smear positive pulmonary
TB patients were registered and interviewed. Among the
subjects interviewed, 1,898 (92%) patients were inter-BMC Public Health 2007, 7:110 http://www.biomedcentral.com/1471-2458/7/110
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viewed within one week after starting treatment. Of the
study subjects, 1,491 (71%) were male. The male-to-
female ratio (2.5:1) reflected the male-to-female ratio of
notified smear positive pulmonary patients in Vietnam in
2002 (2.4:1, NTP unpublished data). Information on
total, patient and HCP delay was available for 2,069
(99%), 2,075 (99%) and 2,034 patients (97%), respec-
tively.
Mean total delay was 7.5 weeks with a median of 4 weeks
(range: 1–48). Total delay tended to be longer among
women and with increasing age, as well as in the northern
part of the country, in rural and remote districts settings,
among ethnic minority groups and among patients who
presented initially to a pharmacy or a communal health
post (Table 1).
Mean patient delay was 4.7 weeks, with a median of 3
weeks (range: 1–48). Men reported earlier with TB symp-
toms than women (4.4 and 5.6 weeks respectively, p <
0.005). Increasing age and increasing distance between
the patient's home and the health care facility visited ini-
tially were associated with longer patient delay (p < 0.05).
Mean patient delay was longer for patients who initially
visited public health facilities such as communal health
posts (6.1 weeks), district health centers (5.9 weeks) or
hospitals (4.5 weeks) than for patients who first visited
traditional healers (3.9 weeks), private practitioners (3.3
weeks) or pharmacies (1.9 weeks) (p < 0.005). Patients
delays were also longer in remote (7.1 weeks) or rural set-
tings compared to urban settings (5.3 weeks, p < 0.005),
and in the northern region (9.1 weeks, p < 0.005).
Table 1: Characteristics of, and total delays among 2,093 new smear-positive pulmonary tuberculosis patients in Vietnam
N (%) Total delay in weeks Percentage due to 
patient delay
Mean (95% CI) P-value Median (25–75 percentiles)
Time (weeks) 7.5 (6.8–7.5) 4 (3–8) 62.7%
Sex < 0.001
Men 1491 (71.4) 7.1 (6.4–7.8) 4 (3–8) 62.0%
Women 596 (28.6) 8.4 (7.4–9.4) 5 (4–9) 66.7%
Age (years) 0.001
0–24 187 (9.1) 5.6 (5.0–6.3) 4 (3–8) 60.7%
25–34 328 (15.9) 6.3 (5.4-7.1) 4 (3–8) 61.9%
35–44 445 (21.7) 8.1 (6.1–10.1) 4 (3–8) 58.0%
45–54 378 (18.4) 7.5 (6.5–8.5) 4 (3–8) 68.0%
55–64 251 (12.2) 8.1 (6.7–9.4) 5 (3–9) 66.7%
65+ 464 (22.6) 8.2 (6.9–9.4) 5 (4–8) 64.6%
Ethnicity 0.048
Viet 1944 (94.0) 7.4 (6.8–8.0) 4 (3–8) 62.2%
Ethnic minority 124 (6.0) 8.4 (6.7–10.0) 5 (4–9) 86.9%
Education level 0.013
Low 895 (42.9) 7.5 (6.8–8.2) 4 (3–8) 65.3%
Middle 793 (38.1) 7.5 (6.8–8.2) 5 (3–8) 64.0%
High 396 (19.0) 7.3 (5.1–9.5) 4 (3–8) 57.5%
Distance from health facility 0.373
0–5 km 1504 (73.4) 7.5 (6.7–8.2) 4 (3–8) 57.3%
More than 5 km 544 (26.6) 7.2 (6.4–8.1) 4 (3–8) 77.8%
Health care provider visited initially because of cough < 0.001
District health center 339 (16.3) 6.6 (5.9–7.2) 4 (3–8) 89.4%
Commune health post 620 (29.9) 9.1 (6.3–11.9) 5 (4–8) 67.0%
Public hospital 360 (17.4) 5.6 (4.9–6.3) 4 (2–6) 80.4%
Pharmacy 326 (15.7) 9.0 (8.0–9.9) 6 (4–12) 21.1%
Private physician 339 (16.3) 7.2 (6.2–8.2) 4 (3–8) 45.8%
Traditional healer 32 (1.5) 6.7 (5.0–8.4) 6 (4–8) 58.2%
Other 59 (2.8) 12.7 (6.5–18.8) 4 (3–10) 78.7%
Area < 0.001
Rural 1029 (49.2) 8.1 (7.4–8.9) 5 (4–8) 65.4%
Urban 808 (38.6) 5.8 (5.4–6.2) 4 (3–7) 56.9%
Remote 256 (12.2) 9.9 (6.4–13.3) 5 (3–9) 71.7%
Region (n = 2,087) < 0.001
South 1316 (62.9) 5.7 (5.3–6.0) 4 (3–6) 52.6%
North 567 (27.1) 11.2 (9.3–13.1) 6 (4–10) 81.3%
Central 210 (10.0) 8.6 (7.2–10.0) 5 (4–9) 44.2%BMC Public Health 2007, 7:110 http://www.biomedcentral.com/1471-2458/7/110
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Patient delay accounted for 63% of total delay overall.
This proportion was lowest for patients who initially vis-
ited a pharmacy (21%) or a private practitioner (46%), or
who lived in the central region (44%). The proportion of
patient delay out of total delay was highest for patients
who initially visited a district health center (89%) or pub-
lic hospital (80%), patients who belonged to ethnic
minorities (87%), and patients who lived in the northern
region (81%) (Table 1).
Mean health care provider (HCP) delay was 2.8 weeks
with a median of 1 week (range: 0–25). HCP delays were
longer for women (2.9 weeks, p < 0.005) and for patients
aged 34–45 years (3.5 weeks) or 65 years or more (3.1
weeks). HCP delays were also longer for patients with a
high level of education (3.2 weeks), or who visited ini-
tially the private sector (p < 0.001), as well as for patients
living at more than 5 km distance from the health facility
(p < 0.005), patients living in rural areas (p < 0.001), and
patients in the central region (p < 0.001)
Long total delay was observed for 305 patients (15%, 95%
CI 13%–16%), long patient delay for 434 (21%, 95% CI
19%–23%), and long HCP delay for 248 (12%, 95% CI
11%–14%). Of 1,731 patients with a total delay ≤ 12
weeks, 99 (6%) reported long HCP delay and 239 (14%)
long patient delay (p < 0.001). Of 303 patient with long
total delay, 128 (42%) reported long HCP delay, 154
(51%) reported long patient delay, and 21 (7%) reported
both (p < 0.001). Thus, patient delay contributed most to
long total delay.
In a logistic regression model, long total delay was signif-
icantly associated with initial visit to a pharmacy
(adjusted odds ratio, aOR 4.3) or a private practitioner
(aOR 1.7). In addition, it was associated with middle age
(aOR 1.8 for 34–44 years and aOR 2.1 for 44–54 years),
with living in remote areas (aOR 1.6) and with living in
the central or northern compared to the southern region
(aOR 3.8 and aOR 2.9 respectively; Table 2).
Table 2: Univariate and multivariate analysis of risk factors associated with long delay among new smear-positive pulmonary 
tuberculosis patients in Vietnam
Long total delay Long patient delay Long HCP delay
N (%) OR aOR* 
(95% CI)
N (%) OR aOR* 
(95% CI)
N (%) OR aOR* (95% CI)
Sex
Men 189/1447 (12.8) 1 1 285/1,476 (19.3) 1 1 169/1449 (11.7) 1 1
Women 115/586 (19.6) 1.7 1.6 (1.3–2.2) 149/593 (25.1) 1.4 1.3 (1.0–1.7) 78/579 (13.5) 1.2 1.2 (0.8–1.7)
Age (years)
0–24 18/186 (9.7) 1 1 30/186 (16.1) 1 1 20/184 (10.9) 1 1
25–34 35/323 (10.8) 1.1 1.2 (0.6–2.2) 60/326 (18.4) 1.2 1.1 (0.7–1.9) 32/316 (10.1) 0.9 0.9 (0.5–1.8)
35–44 72/443 (16.3) 1.8 1.8 (1.0–3.2) 81/439 (18.5) 1.2 1.1 (0.6–1.8) 61/434 (14.1) 1.3 1.2 (0.6–2.2)
45–54 66/374 (17.7) 2.0 2.1 (1.2–3.8) 81/375 (21.6) 1.4 1.2 (0.7–2.0) 44/369 (11.9) 1.1 1.2 (0.6–2.3)
55–64 38/249 (15.3) 1.7 1.4 (0.7–2.7) 61/251 (24.3) 1.7 1.1 (0.7–2.0) 24/246 (9.8) 0.9 0.9 (0.4–1.9)
65+ 73/455 (16.0) 1.8 0.9 (0.8–2.6) 113/458 (24.7) 1.7 1.2 (0.7–2.0) 65/446 (14.6) 1.4 1.6 (0.8–2.9)





78/617 (12.6) 1 1 197/620 (31.8) 1 1 7/611 (1.2) 1 1
Commune health 
post
46/333 (13.8) 1.0 0.9 (0.6–1.4) 92/339 (27.1) 0.8 0.6 (0.4–0.8) 22/330 (6.7) 5.8 6.3 (2.6–15.2)
Public hospital 39/357 (10.9) 0.8 1.1 (0.7–1.7) 77/260 (21.4) 0.6 0.8 (0.6–1.2) 15/355 (4.2) 3.2 3.3 (1.3–8.3)
Pharmacy 81/322 (25.2) 2.3 4.3 (2.9–6.5) 18/326 (5.5) 0.1 0.2 (0.1–0.4) 135/321 (42.1) 59.0 66.0 (29.6–147.3)
Private physician 43/337 (12.8) 1.0 1.7 (1.1–2.6) 31/339 (9.1) 0.2 0.4 (0.2–0.6) 54/331 (16.3) 15.6 16.1 (7.1–36.6)
Traditional healer 5/31 (16.1) 1.3 2.0 (0.7–5.7) 5/32 (15.6) 0.4 0.5 (0.2–1.4) 8/29 (27.6) 31.8 41.5 (13.3–129.3)
Other 13/44 (22.8) 1.9 2.3 (1.1–4.9) 14/59 (23.7) 0.7 0.8 (0.4–1.5) 7/57 (12.3) 9.9 10.6 (3.4–33.3)
Area
Rural 159/1016 (15.7) 1 1 245/1023 (24.0) 1 1 120/1002 (12.0) 1 1
Urban 99/800 (12.4) 0.8 1.0 (0.7–1.4) 109/798 (13.7) 0.5 0.7 (0.5–0.9) 111/673 (14.2) 1.2 1.6 (1.1–2.2)
Remote 47/253 (18.6) 1.3 1.6 (1.1–2.3) 80/254 (31.5) 1.5 1.2 (0.8–1.7) 17/248 (6.9) 0.5 1.4 (0.8–2.6)
Region
South 134/1302 (10.3) 1 1 143/1305 (11.0) 1 1 175/1280 (13.7) 1 1
North 129/558 (23.1) 2.6 3.8 (2.7–5.4) 261/561 (46.5) 7.4 4.9 (3.7–6.5) 28/547 (5.1) 0.3 1.0 (0.6–1.6)
Central 42/209 (20.1) 2.3 2.9 (1.9–4.4) 20/209 (14.4) 1.5 1.4 (0.9–2.2) 45/207 (21.7) 1.8 3.0 (1.9–4.8)
Total 305/2069 (14.7) 434/2075 (20.9) 248/2034 (12.2)
Long total delay: ≥ 12 weeks. Long patient delay: ≥ 6 weeks. Long HCP delay: ≥ 6 weeks. * Adjusted for variables of sex, age, initial visit, area and 
region in the model. OR: Odds ratio; aOR: adjusted odds ratio. 95% CI: 95% confident interval. HCP: Health care provider.BMC Public Health 2007, 7:110 http://www.biomedcentral.com/1471-2458/7/110
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The logistic regression models for long patient delay and
HCP delay showed opposite associations with initial
health care provider (Table 2). Long patient delay was
more common among patients who initially visited a
public provider, whereas long HCP delay was substan-
tially more common among patients who initially visited
a private provider. Compared to the district health center
as the initial provider, the relative risks were 66 for phar-
macy, 42 for traditional healer, and 16 for private practi-
tioner. Other independent risk factors for long patient
delay were female sex, belonging to an ethnic minority,
living at more than 5 km distance from the DTU, and res-
idence in the northern region. Other independent risk fac-
tors for long HCP delay were living at more than 5 km
distance from the DTU and residence in the central region
(Table 2).
In each of the logistic regression models there was signifi-
cant interaction related to the initial HCP. For total delay,
this differed significantly by region. Compared to a public
health facility as first provider, the risk of long total delay
when the first provider was a pharmacy, private practi-
tioner, traditional healer or other private provider was 3.9
times increased (OR 3.9, 95% CI 2.6–6.1) in the south
and 2.8 times (OR 2.8, 95% CI 1.3–6.1) in the center, but
only 1.2 times in the north (OR 1.2, 95% CI 0.7–2.3; like-
lihood ratio test for interaction: p < 0.01). The risk of long
patient delay if the first provider was private rather than
public was reduced by half among men (OR 0.5, 95% CI
0.4–0.8), but to one third among women (OR 0.3, 95%
CI 0.1–0.5; p < 0.05). The risk of long HCP delay if the
first provider was private rather than public was 10.5
times increased in rural districts (OR 10.5, 95% CI 5.9–
18.6) and 16.8 times in urban districts (OR 16.8, 95% CI
9.0–31.7), but only 3.9 times in remote districts (OR 3.9,
95% CI 1.2–2.5; p < 0.05).
The associations with initial provider were further ana-
lyzed by comparing the distribution of delay periods (Fig-
ures 1, 2 and 3). Eighty-eight percent of patients who
initially visited a public provider had been detected and
started treatment within 12 weeks, compared to 81% of
patients who initially visited a private provider (p <
0.001). Of the patients who initially visited a public pro-
vider, 72% had reported with symptoms within 6 weeks
of onset, compared to 92% of patients who initially vis-
ited a private provider (p < 0.001). Within 6 weeks of the
initial visit, 97% of patients had started TB treatment if the
initial provider had been public, compared to 71% if the
initial provider had been private (p < 0.001). Overall,
patients with long total delay accounted for 49% of the
cumulative number of delay-weeks of all patients. This
was 62% both for long patient and for long HCP delay.
Discussion
This study showed an overall mean time from onset of
cough to TB treatment for new smear-positive pulmonary
TB patients in Vietnam of 7.5 weeks. This is almost half
less than the delay reported from 4 provinces in Vietnam
in 1996 (13.3 weeks) [12], and much lower than the delay
reported from other high-prevalence countries such as
Nepal [19], South Africa [20], Tanzania [2], Ethiopia [3,4]
and Thailand [7], where it ranged from 9 to 23 weeks.
Patient delay (on average 4.7 weeks) contributed more
than HCP delay (on average 2.8 weeks) to the total delay
in our study. In 1996 mean patient delay was 5.8 weeks
and mean HCP delay was 6.1 weeks [12]. Although the
study in 1996 measured delay by onset of any TB symp-
tom instead of just cough, and was not representative for
Cumulative proportion of patient, health care provider and  total delay among new smear-positive tuberculosis patients  who initially visited public health care providers Figure 2
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Vietnam, the data suggest a decrease in total delay since
1996 that is primarily due to a decrease in HCP delay.
The short delay found in our study may be explained by
the development of the general health care and TB control
network in Vietnam over the past years [21,22]. This may
have impacted both on patient and on HCP delays. Access
of the poor to basic health services has been improved by
providing free health cards, user fee exemption, reim-
bursement of travel cost and other enablers [21,22].
Knowledge of commune health staff and volunteers at vil-
lage level also has improved over the recent years. A com-
munity health network enhances detection and referral of
patients who are suspect of having TB to the appropriate
level for diagnosis [23]. Health information campaigns
may have raised the awareness of the community about
TB symptoms and the need for timely diagnosis [23].
We found clear associations between delay and the type of
health care provider first visited by the patient because of
cough. Long patient delays were most frequent if this had
been the district health centre, and least frequent if this
had been a private provider. Long HCP delays were how-
ever more frequent among patients who visited a private
provider first, as were long total delays. These findings are
in accordance with data from Ho Chi Minh City, where,
compared to public providers, relative risks for long HCP
delay were 5.5 for private pharmacies as the first provider,
and 2.1 for private physicians as the first provider [13].
Thus, although initial visits to private health services
tended to be earlier after the onset of cough than initial
visits to public health services, the time until diagnosis of
TB tended to be longer, to the net effect of longer delays if
the initial provider had been private. This suggests that
referral from the private sector is an important problem.
One-third of all patients in our study had initially visited
a private provider, although this proportion was higher in
the southern (44%) and central (37%) than in the north-
ern region (8%). Also, the observed interaction indicates
that referral from private providers is less of a problem in
the north and in remote settings. Education on diagnosis
of TB of private health care providers and pharmacies may
help prevent long health care provider delays, as may
implementation of public-private mix DOTS projects in
urban and rural areas, in particular in the southern and
central regions. The growth of the private sector in Viet-
nam and its impact on diagnostic delay warrant regular
monitoring of these delays.
The 21% of patients who had patient delays of more than
6 weeks accounted for 61% of the cumulative patient
delay period, and the 13% of patients who had HCP delay
of more than 6 weeks accounted for 62% of the cumula-
tive HCP delay. It supports our hypothesis that efforts
should not be put in further reduction of total median
delay, but in prevention of long delays, since they contrib-
ute most to the cumulative delay of all patients and
thereby to transmission.
The sex difference in delay is small and similar to the dif-
ference found by previous studies [12,14,15,24-26]. These
longer delays among women, as well as the low propor-
tion of women among patients in this study and among
notified TB patients in Vietnam in general, may indicate
lower access to diagnosis and treatment of TB for women
compared to men [12,25,26]. However, biological differ-
ences between men and women with respect to TB inci-
dence and sensitivity of smear examination may play a
role as well [24,27]. Analysis of model interactions sug-
gests that, although women tend to report with cough to
private providers earlier than men, this does not result in
shorter overall delays, supporting earlier findings that
health care providers visited by women tend to be less
qualified [24,25]. These analyses showed other risk factors
for long delay that may help target interventions, such as
belonging to an ethnic minority, living in particular geo-
graphic areas, middle age and female sex.
There were several limitations to our study. First, the
reported duration of symptoms is based on the patients'
recall and interpretation. Recall bias is thus a serious
threat to the estimates of delay and actions taken. Unfor-
tunately there is no feasible method which can deal with
this problem. Second, selection of patients might be
biased. Some patients diagnosed within the NTP may
have been referred to other facilities or have sought treat-
ment in the private sector before they were registered.
These patients were not included in our study. Third, both
health workers and patients can contribute to long HCP
delay: patients can delay the start of treatment as well as
Cumulative proportion of patient, health care provider and  total delay among new smear-positive tuberculosis patients  who initially visited private health care providers Figure 3
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the health worker, e.g. for fear of stigmatization or reluc-
tance to tell employers [28]. Finally, the observed associa-
tion of long delay with private health care provider does
not necessarily imply causation. Patients may have been
more "at risk" of visiting a private practitioner simply
because more time elapsed between onset of symptoms
and diagnosis at the TB unit.
Conclusion
On average, total, patient and health care provider delays
were short in this nation-wide study of TB patients in Viet-
nam. Nonetheless, 15% of patients reported total delays ≥
12 weeks, and accounted for half of the cumulative
number of delay-weeks. Initial visit to the private sector
had a considerable impact on the length of delays but
with distinct regional differences across the country.
Efforts should be made to further reduce diagnostic delays
by improving the referral from the private to the public
health sector.
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